The ImmunoCARE study, led by scientists at Scripps Research in collaboration with Cue Health (a San Diego-based company), hopes to enroll 10,000 immunocompromised people nationwide. The study will provide half of the participants with ten highly sensitive nucleic acid amplification tests every month. The goal of the study is to see if early detection and rapid administration of antiviral medication can reduce hospitalizations in highly vulnerable populations. To watch additional Morning segments, go to https://www.cbs8.com/mornings